Caveolin-1 sensitizes rat pituitary adenoma GH3 cells to bromocriptine induced apoptosis

BACKGROUND: Prolactinoma is the most frequent pituitary tumor in humans. The dopamine D(2 )receptor agonist bromocriptine has been widely used clinically to treat human breast tumor and prolactinoma through inhibition of hyperprolactinemia and induction of tumor cell apoptosis, respectively, but the...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yan-Nian, Li, Yi-Hung, Ke, Meng-Wei, Tseng, Ting-Yu, Tang, Yueh-Bih, Huang, Mu-Chiou, Cheng, Winston Teng-Kuei, Ju, Yu-Ten
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1832175/
https://www.ncbi.nlm.nih.gov/pubmed/17331262
http://dx.doi.org/10.1186/1475-2867-7-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1832175/
https://www.ncbi.nlm.nih.gov/pubmed/17331262
http://dx.doi.org/10.1186/1475-2867-7-1

Ejemplares similares